- Home
- Companies
- canada nunavut
- biomarker development
Refine by
Biomarker Development Suppliers Serving Canada Nunavut
47 companies found
Premium
based inFramingham, MASSACHUSETTS (USA)
SCIEX empowers you to solve the most impactful analytical challenges in quantitation and characterization in environmental testing. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field ...
based inSeattle, WASHINGTON (USA)
Headquartered in Seattle, Avaden Biosciences operates the largest human biosample network in the world. Our U.S.-based partnerships with over 200 CLIA/CAP accredited facilities provide immediate access to more than 35,000,000 highly annotated ...
based inEschborn, GERMANY
When we looked at the decision making landscape in organizations and observed that the available technologies and models were helping make decisions but with fixed cycles of information processing, running in batches, with little flexibility and ...
Identify the biomarkers best suited for your needs: Diagnose rare or ambiguous diseases, Group patients by endotype response for prognosis, Assess disease etiology to determine responsive patient group ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
based inPortland, MAINE (USA)
Ovation advances human health by enabling the use of molecular and human genomic data at scale for researchers developing precision medicines. We’re on a mission to advance human health by enabling the use of molecular and human genomic data at ...
Ovation's genomic data solutions enable life science and biopharma companies to accelerate research and development across a wide range of therapeutic areas including autoimmune, metabolic, and infectious ...
based inVista, CALIFORNIA (USA)
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating chronic autoimmune diseases. Our portfolio of innovative products enable timely differential diagnosis, prognosis, management, and optimization of ...
Exagen Inc. is a CLIA-certified, CAP-accredited specialty laboratory that offers a variety of unique biomarkers and patented methodologies to support clinical research and development in autoimmune diseases. Our ...
based inUppsala, SWEDEN
Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing outstanding products and services for human protein biomarker discovery. Our groundbreaking Olink panels for precision proteomics help ...
Casting a broader net to further explore the complexity of the human proteome. Complementing and expanding on our previous portfolio of disease area-focused biomarker panels, our exploratory panels offers scientists the chance to cast a wider net in ...
based inSouth San Francisco, CALIFORNIA (USA)
BioCheck, located in the San Francisco Bay Area, was founded in April 1997, to develop and manufacture high-quality enzyme immunoassay test kits for the worldwide biomedical, pharmaceutical and scientific research markets. The founders have brought ...
based inNavi Mumbai, INDIA
Yashraj Biotech Limited manufactures a wide range of high pure biomarkers in the form of native and recombinant proteins that are used by the diagnostic industry as controls, calibrators and immunogens. YBL has been the preferred partner of most of ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
We optimize your lead compounds using expertise and data-driven decisions. The lead optimization stage marks the end of the drug discovery phase and the start of pharmaceutical or biological development. Insight into the absorption, distribution, ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Veracyte’s Cancer Immune Atlas allows clinical researchers to maximize the value of the data generated through our Immunogram analysis platform. The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), nutritional health, ...
based inNewton, MASSACHUSETTS (USA)
BioSensics is a global leader in development of wearable sensors and digital platforms for clinical trials, patient monitoring and health assessment. BioSensics was founded in 2007 by three scientists from Harvard University with a vision of ...
A transformative mobile health application for monitoring motor, speech and cognitive function, and mental ...
based inSharnbrook, UNITED KINGDOM
AgPlus Diagnostics is proud to present the Agilis Reader. A portable diagnostic solution, comparable to any fixed laboratory analyzer, The Agilis Reader is a quantitative diagnostic reader that can be used in multiple market applications that when ...
We are proud to have developed a tried and tested B2B commercial approach. We strive to progress partnerships including technology licensing, assay development plus manufacture and supply, with collaborators in a variety of applications and business ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
NEUROLINCS : A non-invasive in-vitro diagnostic test measuring 7494 brain-enriched long non-coding RNAs (lncRNAs) that are specific to neurodegenerative ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
Biomarkers are measurable traits that serve as indicators of normal biological activities, disease processes, or pharmacological responses to therapeutic interventions. Peptides are particularly suitable as biomarkers due to their ability to ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
based inSeongnam-si, SOUTH KOREA
Theramx Inc. was founded on the conviction that health, and the extension of life, is one of the important values that can be provided to humankind. Our company develops treatment platforms that provide the best diagnoses and treatments. As a ...
Technology that excavates biomarkers through an analysis of brainwaves in epilepsy or Alzheimer’s patients, predicts the likelihood of onset, or diagnoses the advance, based on the degree of change of brainwave biomarkers measured by a ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
